Abraxis BioScience is an integrated, global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures, and markets one of the broadest portfolios of injectable products and innovates revolutionary core technology such as its nab technology platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases.